logo
Plus   Neg
Share
Email

Deutsche Bank, BNP Paribas In Deal For Prime Finance And Electronic Equities

Deutsche Bank AG (DB) announced Monday that it has signed a master transaction agreement with BNP Paribas SA (BNPQY.PK,BNP.L) to provide continuity of service to Deutsche Bank's Global Prime Finance and Electronic Equities clients.

Under the agreement, Deutsche Bank will continue to operate the platform until clients can be migrated to BNP Paribas. The transition for clients will be through the migration of technology and key staff from Deutsche Bank to BNP Paribas. This binding agreement remains subject to regulatory approvals of the relevant authorities.

Bloomberg had reported, citing a people familiar with the matter, that Deutsche Bank was nearing a deal to transfer its prime brokerage business to BNP Paribas.

Frank Kuhnke, Chief Operating Officer, Deutsche Bank, said, "We are pleased to have signed the master transaction agreement with BNP Paribas on schedule. This is an important milestone for our Capital Release Unit and attests to the strength of our client offering and technology in these products. We are already making progress and are on the right track to implement this transaction, thereby providing a clear path for clients and staff."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
PG&E agreed to pay around $13.5 billion to settle all individual claims related to California wildfires, due to which the electric utility had to file for bankruptcy. With the Bankruptcy Court's approval of the settlement agreement, PG&E hopes to emerge from Chapter 11 by the June 30, 2020 deadline to participate in the State of California's go-forward wildfire fund. Airbnb has introduced few new rules to control parties and nuisances amidst the backlash the service received after the Halloween shooting at an Airbnb rental in a San Francisco. San Francisco-based Airbnb said it is banning "open invite" parties at all of its accommodations. The company is also banning... The U.S. Food and Drug Administration has approved three generic versions of Novartis' Gilenya capsule for treating relapsing forms of multiple sclerosis. "Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA," said Janet Woodcock, director...
Follow RTT
>